Daily weight loss pill can help cut body weight by a fifth, trial shows

Eli Lilly's new weight loss pill, orforglipron, has shown promising results in a clinical trial. The once-a-day tablet, which targets the GLP-1 receptors like other weight loss injections, was tested on 3,127 adults over 72 weeks. The trial found that one in five participants lost 20% or more of their body weight while taking the pill. This suggests that the drug could be a viable option for those seeking to shed a significant amount of weight, potentially paving the way for its wider adoption.
Source: For the complete article, please visit the original source link below.